Dr. Michael Gould, MD

NPI: 1902825847
Total Payments
$2.7M
2024 Payments
$555,594
Companies
5
Transactions
261

Payment Breakdown by Category

Consulting$2.6M (99.5%)
Travel$12,970 (0.5%)
Food & Beverage$366.76 (0.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $2.6M 216 99.5%
Travel and Lodging $12,970 36 0.5%
Food and Beverage $366.76 9 0.0%

Top Paying Companies

Company Total Records Latest Year
Allergan, Inc. $2.0M 194 $0 (2023)
ABBVIE INC. $637,240 63 $0 (2024)
AstraZeneca Pharmaceuticals LP $121.09 2 $0 (2020)
CSL Behring $23.75 1 $0 (2017)
E.R. Squibb & Sons, L.L.C. $14.41 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $555,594 55 ABBVIE INC. ($555,594)
2023 $498,913 63 Allergan, Inc. ($417,267)
2022 $486,748 57 Allergan, Inc. ($486,748)
2021 $579,350 53 Allergan, Inc. ($579,336)
2020 $99.72 1 AstraZeneca Pharmaceuticals LP ($99.72)
2019 $169.97 4 Allergan Inc. ($148.60)
2018 $108,000 3 Allergan Inc. ($108,000)
2017 $424,602 25 Allergan Inc. ($424,578)

All Payment Transactions

261 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
12/23/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,512.80 General
12/14/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,512.80 General
12/08/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,512.80 General
12/01/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $8,446.14 General
11/24/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,512.80 General
11/18/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,512.80 General
11/11/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,512.80 General
11/04/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,199.98 General
10/28/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,512.80 General
10/24/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,512.80 General
10/14/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,512.80 General
10/07/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $11,887.16 General
09/29/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,512.80 General
09/23/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,512.80 General
09/16/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $11,887.16 General
09/09/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $9,697.42 General
09/02/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $10,635.88 General
08/26/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,199.98 General
08/19/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $10,635.88 General
08/12/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $12,512.80 General
08/05/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $11,574.34 General
08/05/2024 ABBVIE INC. Travel and Lodging In-kind items and services $571.83 General
08/05/2024 ABBVIE INC. Travel and Lodging In-kind items and services $397.46 General
08/05/2024 ABBVIE INC. Travel and Lodging In-kind items and services $155.85 General
08/05/2024 ABBVIE INC. Travel and Lodging In-kind items and services $133.33 General

About Dr. Michael Gould, MD

Dr. Michael Gould, MD is a Emergency Medicine healthcare provider based in Somerville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902825847.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Gould, MD has received a total of $2.7M in payments from pharmaceutical and medical device companies, with $555,594 received in 2024. These payments were reported across 261 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($2.6M).

Practice Information

  • Specialty Emergency Medicine
  • Location Somerville, NJ
  • Active Since 07/19/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1902825847

Products in Payments

  • ALLODERM (Device) $532,578
  • LOKELMA (Drug) $99.72
  • Kcentra (Biological) $23.75
  • ELIQUIS (Drug) $14.41

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Somerville